Your browser doesn't support javascript.
loading
A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders.
Khoury, Tawfik; Ishay, Yuval; Rotnemer-Golinkin, Devorah; Zolotarovya, Lidya; Arkadir, David; Zimran, Ari; Ilan, Yaron.
Afiliação
  • Khoury T; Gastroenterology and Liver Units, Department of Medicine, The Hebrew University, Hadassah Medical School, Jerusalem, Israel.
  • Ishay Y; Gastroenterology and Liver Units, Department of Medicine, The Hebrew University, Hadassah Medical School, Jerusalem, Israel.
  • Rotnemer-Golinkin D; Gastroenterology and Liver Units, Department of Medicine, The Hebrew University, Hadassah Medical School, Jerusalem, Israel.
  • Zolotarovya L; Gastroenterology and Liver Units, Department of Medicine, The Hebrew University, Hadassah Medical School, Jerusalem, Israel.
  • Arkadir D; Department of Neurology, Hadassah-Hebrew University Medical Center, Israel.
  • Zimran A; Gaucher Clinic, Shaare Zedek Medical Center (SZMC), The Hebrew University, Hadassah Medical School, Jerusalem, Israel.
  • Ilan Y; Gastroenterology and Liver Units, Department of Medicine, The Hebrew University, Hadassah Medical School, Jerusalem, Israel. Electronic address: Ilan@hadassah.org.il.
Biomed Pharmacother ; 132: 110890, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33080465

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Ambroxol / Glucosilceramidas / Hepatite / Fatores Imunológicos / Fígado / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Israel País de publicação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Ambroxol / Glucosilceramidas / Hepatite / Fatores Imunológicos / Fígado / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Israel País de publicação: França